Inhibition of protein SUMOylation by davidiin, an ellagitannin from Davidia involucrata

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of antibiotics (Tokyo. 1968)

• Publication date

  2014-01-15

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1038/ja.2013.142PMID 24424345
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The role of EZH 2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells

  2016cited by this paper
• A potential antitumor ellagitannin, davidiin, inhibited hepatocellular tumor growth by targeting EZH2

  2013cited by this paper
• Spectomycin B 1 as a Novel SUMOylation Inhibitor That Directly Binds to SUMO E 2

  2013cited by this paper
• Spectomycin B1 as a novel SUMOylation inhibitor that directly binds to SUMO E2.

  2013cited by this paper
• An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation.

  2013cited by this paper
• Total synthesis of (+)-davidiin.

  2012cited by this paper
• The Role of EZH2 in the Regulation of the Activity of Matrix Metalloproteinases in Prostate Cancer Cells

  2012cited by this paper
• A SUMOylation-Dependent Transcriptional Subprogram Is Required for Myc-Driven Tumorigenesis

  2012cited by this paper
• Kerriamycin B inhibits protein SUMOylation

  2009cited by this paper
• Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate.

  2009cited by this paper
• The Polycomb Repressive Complex 2 Is a Potential Target of SUMO Modifications

  2008cited by this paper
• SUMO on the road to neurodegeneration.

  2007cited by this paper
• Role of SUMO/Ubc9 in DNA Damage Repair and Tumorigenesis

  2006cited by this paper
• Viruses and sumoylation: recent highlights

  2006cited by this paper
• In situ SUMOylation analysis reveals a modulatory role of RanBP2 in the nuclear rim and PML bodies.

  2006cited by this paper
• Protein modification by SUMO.

  2004cited by this paper
• Generation of SUMO‐1 modified proteins in E. coli: towards understanding the biochemistry/structural biology of the SUMO‐1 pathway

  2004cited by this paper
• SUMO in Cancer - Wrestlers Wanted

  2002cited by this paper
• Plant polyphenols: biologically active compounds or non-selective binders to protein?

  1997cited by this paper
• Tannins of Euphorbiaceous Plants. X. Antidesmin A, a New Dimeric Hydrolyzable Tannin from Antidesma pentandrum var. barbatum

  1992cited by this paper
• Gallotannins having a 1,5-anhydro-D-glucitol core and some ellagitannins from Acer species

  1990cited by this paper
• The metabolism of gallic acid and hexahydroxydiphenic acid in plants. Part 3. Esters of (R)- and (S)-hexahydroxydiphenic acid and dehydrohexahydroxydiphenic acid with D-glucopyranose (1C4 and related conformations)

  1982cited by this paper

• SUMOylation and anticancer drug resistance.

  2026cites this paper
• Blockage of SUMO E1 enzyme inhibits ocular lens fibrosis by mediating SMAD4 SUMOylation

  2025cites this paper
• SUMO E1 covalent allosteric inhibitors upregulate polyamine synthesis via the MAT2A-AdoMetDC axis.

  2025cites this paper
• High-quality chromosome-level genome assembly of Davidia involucrata reveals evolutionary insights into tannin biosynthesis and bract development

  2025cites this paper
• An Innovative Strategy for Untargeted Mass Spectrometry Data Analysis: Rapid Chemical Profiling of the Medicinal Plant Terminalia chebula Using Ultra-High-Performance Liquid Chromatography Coupled with Q/TOF Mass Spectrometry–Key Ion Diagnostics–Neutral Loss Filtering

  2025cites this paper
• The impact of dysregulation SUMOylation on prostate cancer

  2025cites this paper
• The intricate relationship between SUMOylation and gliomas: a review with a perspective on natural compounds.

  2025cites this paper
• Targeted inhibition of SUMOylation: treatment of tumors

  2024cites this paper
• Unveiling the Pharmacological Mechanisms of Davidiin’s Anti-Diabetic Efficacy in Streptozotocin-Treated Rats: A Comprehensive Analysis of Serum Metabolome

  2024cites this paper
• Distinctive tumorigenic significance and innovative oncology targets of SUMOylation

  2024cites this paper
• Targeted DeSUMOylation as a therapeutic strategy for multiple sclerosis.

  2024cites this paper
• The SUMO Family: Mechanisms and Implications in Thyroid Cancer Pathogenesis and Therapy

  2024cites this paper
• Paradoxes of Cellular SUMOylation Regulation: A Role of Biomolecular Condensates?

  2023cites this paper
• First report of Mesoptyelus nigrifrons on the dove tree (Davidia involucrata Baill.) in China

  2023cites this paper
• Unraveling the Post-Translational Modifications and therapeutical approach in NSCLC pathogenesis

  2023cites this paper
• Develop quantitative FRET (qFRET) technology as a high-throughput universal assay platform for basic quantitative biomedical and translational research and development

  2023cites this paper
• SUMOylation and DeSUMOylation: Prospective therapeutic targets in cancer.

  2023cites this paper
• The SUMOylation and ubiquitination crosstalk in cancer

  2023cites this paper
• The emerging roles of SUMOylation in the tumor microenvironment and therapeutic implications

  2023cites this paper
• Ubiquitin and Ubiquitin-like Proteins in Cancer, Neurodegenerative Disorders, and Heart Diseases

  2022cites this paper
• Small-molecule inhibitors targeting small ubiquitin-like modifier pathway for the treatment of cancers and other diseases.

  2022cites this paper
• Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer.

  2021cites this paper
• E1 Enzymes as Therapeutic Targets in Cancer

  2021cites this paper
• PPAR Modulation Through Posttranslational Modification Control

  2021cites this paper
• Therapeutic Potential of Targeting the SUMO Pathway in Cancer

  2021cites this paper
• Novel insights into the impact of the SUMOylation pathway in hematological malignancies (Review)

  2021cites this paper
• Effects of Targeting Sumoylation Processes During Latent and Induced Epstein-Barr Virus Infections Using the Small Molecule Inhibitor ML-792.

  2021cites this paper
• SUMOylation is a post-translational modification regulating skeletal muscle pathophysiology

  2020cites this paper
• Sumoylation as an Emerging Target in Therapeutics against Cancer.

  2020cites this paper
• Current Status of SUMOylation Inhibitors.

  2020cites this paper
• Targeting SUMO Signaling to Wrestle Cancer.

  2020cites this paper
• Synthesis of All Stereoisomers of Monomeric Spectomycin A1/A2 and Evaluation of Their Protein SUMOylation-Inhibitory Activity.

  2019cites this paper
• How Does SUMO Participate in Spindle Organization?

  2019cites this paper
• Using glycyrrhizic acid to target sumoylation processes during Epstein-Barr virus latency

  2019cites this paper
• SUMOylation in Glioblastoma: A Novel Therapeutic Target

  2019cites this paper
• The role of SUMO pathway in pathophsiology of skeletal muscle

  2019cites this paper
• Post-translational modifications of the Fragile X Mental Retardation Protein in neuronal function and dysfunction

  2019cites this paper
• The SUMO Pathway in Hematomalignancies and Their Response to Therapies

  2019cites this paper
• Molecular mechanism of a covalent allosteric inhibitor of SUMO E1 activating enzyme

  2018cites this paper
• Crystal structure of SUMO E1 in complex with an allosteric inhibitor

  2018cites this paper
• SUMOylation in brain ischemia: Patterns, targets, and translational implications

  2018cites this paper
• Small-Molecule Inhibitors Targeting Protein SUMOylation as Novel Anticancer Compounds

  2018cites this paper
• Viral manipulation of the cellular sumoylation machinery

  2017cites this paper
• Macrophilone A: Structure Elucidation, Total Synthesis, and Functional Evaluation of a Biologically Active Iminoquinone from the Marine Hydroid Macrorhynchia philippina.

  2017cites this paper
• Probing the roles of SUMOylation in cancer cell biology by using a selective SAE inhibitor.

  2017cites this paper
• Ellagitannins of Davidia involucrata. I. Structure of Davicratinic Acid A and Effects of Davidia Tannins on Drug-Resistant Bacteria and Human Oral Squamous Cell Carcinomas

  2017cites this paper
• Pharmacological treats for SUMO addicts.

  2016cites this paper
• Natural Product Inhibitors of Ubiquitin Conjugation and Deconjugation

  2016cites this paper
• Inhibition of protein SUMOylation by natural quinones

  2016cites this paper
• SUMO wrestling with Ras

  2016cites this paper
• Chemically Diverse Secondary Metabolites from Davidia involucrata (Dove Tree)

  2016cites this paper
• A gene-expression screen identifies a non-toxic sumoylation inhibitor that mimics SUMO-less human LRH-1 in liver

  2015influential citation
• Synthetic derivatives of the SUMO consensus sequence provide a basis for improved substrate recognition.

  2015cites this paper
• LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1

  2015cites this paper
• LMP 1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP 1

  2015cites this paper
• Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery.

  2014cites this paper
• Targeting SUMOylation cascade for diabetes management.

  2014cites this paper